Association between diagnosis to treatment interval and survival outcomes in diffuse large B-cell lymphoma using a causal inference approach
Timely care is an important aspect of health care quality, particularly for aggressive malignancies like diffuse large B-cell lymphoma (DLBCL). However, the prognostic impact of diagnosis-to-treatment interval (DTI) in DLBCL remains inconclusive. Thus, we evaluated the impact of DTI on survival outcomes using causal inference methods. A total of 2610 DLBCL patients treated with immunochemotherapy from the Lymphoma and Related Diseases Registry were included. Inverse probability of treatment weighting (IPTW) based on propensity scores estimated via generalized boosted models was applied to adjust for differences in adverse prognostic factors between DTI cohorts. The median DTI was 15 days, with an interquartile range of 8–28 days. Patients who received treatment within 14 days had adverse clinical characteristics, including stage III/IV, poor performance status, elevated LDH, B-symptoms, bulk disease, > 1 extranodal sites involved and anaemia. In univariable analyses, shorter DTI (≤ 14 days) was associated with worse overall survival (OS) and progression-free survival (PFS). However, after IPTW adjustment, shorter DTI was significantly associated with improved OS (adjusted hazard ratio = 0.68; 95% CI: 0.52, 0.88). our study suggest that short DTI should be interpreted primarily as a marker of disease severity rather than as an adverse prognostic factor itself.
Authors
- Eliza Anne Hawkes (ORCID: https://orcid.org/0000-0002-0376-2559)
- Eliza Chung (ORCID: https://orcid.org/0000-0001-6642-1033)
- Adugnaw Zeleke Alem (ORCID: https://orcid.org/0000-0002-1928-8548)
- Nalini Kant Pati (ORCID: https://orcid.org/0000-0001-7448-7294)
- Itismita Mohanty (ORCID: https://orcid.org/0000-0002-9013-1068)
- Cameron J. Wellard (ORCID: https://orcid.org/0000-0002-6115-5394)
- Stephen Opat (ORCID: https://orcid.org/0000-0002-0308-6458)
- Zoe McQuilten (ORCID: https://orcid.org/0000-0001-9698-7185)
- Theophile Niyonsenga
- Erica M. Wood
Institutions
- Australian National University (AU)
- University of Canberra (AU)
- Canberra Hospital (AU)
- Alfred Health (AU)
- Austin Health (AU)
- Olivia Newton-John Cancer Research Institute (AU)
- Monash University (AU)
- University of Gondar (ET)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41598-026-78239-1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government
- University of Canberra